Lv1
60 积分 2025-11-22 加入
Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study
1个月前
已完结
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
1个月前
已完结
CAR-T cell therapy: Where are we now, and where are we heading?
1个月前
已完结
CAR-X cell engineering
1个月前
已完结
Potential of chimeric antigen receptor (CAR) T cell immunotherapy in systemic lupus erythematosus (SLE)
2个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
2个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
3个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
3个月前
已完结
Fever of Unknown Origin
4个月前
已完结
皖公网安备34019202002308
